Genomic & Genetic Technologies Trade Mission to Greece, Turkiye, and Italy

The Genomic & Genetic Technologies Trade Mission to Greece, Turkiye, and Italy will be taking place May 19-23, 2025 to tap into the growing demand for cutting-edge and innovative technologies in these markets. Ongoing human genomics projects and increased screening for genetic and rare diseases provide attractive opportunities for companies engaged in Next Generation Sequencing (NGS) R&D and test kit development, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Bioinformatics, Proteomics, RNA Therapeutics, Molecular Cytogenetics, Molecular Genetics, Cancer Genetics, Pharmacogenetics, Rare Diseases, Pre-natal Genetic Disorders, Preimplantation Genetic Testing (PGT) for In-Vitro Fertilization, and more. Industry snapshots for Greece, Italy, and Turkey can be accessed HERE.

Trade Mission activities include:

• Pre-arranged B2B meetings
• Visits to leading research institutes and laboratories
• Networking events
• Discussions with key government and industry leaders. This mission is suitable for companies who are seeking to expand into Greece, Türkiye, and Italy, and those who already have a presence in these markets can establish new contacts through this program.

Following the conclusion of the mission in Italy, companies may choose to attend or exhibit at the European Society of Human Genetic Conference (ESHG), which will take place in Milan May 24-27, 2025. (Registration is separate and is the responsibility of the U.S. firm.)

Questions? Please contact Michelle Ouellette, Cindy Ma, or Monica Toporkiewicz.